Caxton Associates (New York)’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
GJL
JCP
PAIM
VC
Caxton Associates (New York)'s BXC Position: Q2 2024 in Review
Caxton Associates (New York) sold out of BlueLinx (BXC) in Q2 2024, closing a stake of 10,632 shares — an estimated $1.38M sold.
Caxton Associates (New York) first reported a position in BXC in Q4 2021 and held it in 5 quarters. The position peaked at $1.38M in Q1 2024. 168 funds tracked by Wall St. Rank hold BXC as of Q2 2024.
- Caxton Associates (New York) reported no remaining BlueLinx position as of Q2 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 10,632 BlueLinx shares in Q2 2024, an estimated $1.38M.
- Caxton Associates (New York) first reported a position in BlueLinx in Q4 2021 and held it in 5 quarters.
- Caxton Associates (New York)'s BlueLinx position peaked at $1.38M in Q1 2024.
- 168 funds tracked by Wall St. Rank held BlueLinx as of Q2 2024.
Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.